Royal Philips has obtained 510(k) clearance from the FDA for its BlueControl wearable light therapy device, a technology designed to facilitate at-home treatment of mild psoriasis. The Class II device, which comes with adjustable straps so it can be placed on the affected areas, uses high-intensity blue LEDs to deliver light therapy that decelerates the production of plaque psoriasis-related skin cells.
Royal Philips' wearable light therapy device wins FDA clearance
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.